Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) Short Interest Update

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXTW) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 200 shares, a decrease of 60.0% from the February 29th total of 500 shares. Based on an average daily trading volume, of 1,800 shares, the short-interest ratio is presently 0.1 days.

Lixte Biotechnology Price Performance

Shares of LIXTW stock traded down $0.03 on Thursday, hitting $0.05. The stock had a trading volume of 3,035 shares, compared to its average volume of 5,173. Lixte Biotechnology has a 52-week low of $0.03 and a 52-week high of $0.14. The stock’s 50 day moving average is $0.07 and its 200-day moving average is $0.07.

About Lixte Biotechnology

Lixte Biotechnology Holdings, Inc operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development.